StonvexLoading…
StonvexStonvexStonvexCore line items from CRSR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $354.51M | $1.47B | $1.04B | $689.86M |
Operating Income | $13.80M | $2.08M | $-24.81M | $-19.19M |
Net Income | $12.78M | $-16.16M | $-41.95M | $-31.32M |
EPS (Diluted) | $0.11 | $-0.12 | $-0.35 | $-0.26 |
Total Assets | $1.18B | $1.25B | $1.20B | $1.22B |
Total Liabilities | $516.53M | $608.03M | $587.92M | $606.71M |
Cash & Equivalents | $119.75M | $98.83M | $66.05M | $107.45M |
Free Cash Flow OCF − CapEx | $26.06M | $34.75M | $1.83M | $43.16M |
Shares Outstanding | 106.88M | 106.64M | 104.76M | 104.76M |